CNSP
Price
$7.04
Change
-$0.33 (-4.48%)
Updated
Jan 16 closing price
Capitalization
4.37M
Intraday BUY SELL Signals
VIR
Price
$6.06
Change
-$0.14 (-2.26%)
Updated
Jan 16 closing price
Capitalization
843.1M
33 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CNSP vs VIR

Header iconCNSP vs VIR Comparison
Open Charts CNSP vs VIRBanner chart's image
CNS Pharmaceuticals
Price$7.04
Change-$0.33 (-4.48%)
Volume$67.55K
Capitalization4.37M
Vir Biotechnology
Price$6.06
Change-$0.14 (-2.26%)
Volume$1.67M
Capitalization843.1M
CNSP vs VIR Comparison Chart in %
View a ticker or compare two or three
VS
CNSP vs. VIR commentary
Jan 18, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNSP is a Hold and VIR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 18, 2026
Stock price -- (CNSP: $7.04 vs. VIR: $6.06)
Brand notoriety: CNSP and VIR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CNSP: 175% vs. VIR: 92%
Market capitalization -- CNSP: $4.37M vs. VIR: $843.1M
CNSP [@Biotechnology] is valued at $4.37M. VIR’s [@Biotechnology] market capitalization is $843.1M. The market cap for tickers in the [@Biotechnology] industry ranges from $111.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CNSP’s FA Score shows that 2 FA rating(s) are green whileVIR’s FA Score has 1 green FA rating(s).

  • CNSP’s FA Score: 2 green, 3 red.
  • VIR’s FA Score: 1 green, 4 red.
According to our system of comparison, CNSP is a better buy in the long-term than VIR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CNSP’s TA Score shows that 4 TA indicator(s) are bullish while VIR’s TA Score has 5 bullish TA indicator(s).

  • CNSP’s TA Score: 4 bullish, 5 bearish.
  • VIR’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, VIR is a better buy in the short-term than CNSP.

Price Growth

CNSP (@Biotechnology) experienced а +20.96% price change this week, while VIR (@Biotechnology) price change was +3.59% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.24%. For the same industry, the average monthly price growth was +4.14%, and the average quarterly price growth was +42.40%.

Reported Earning Dates

VIR is expected to report earnings on Feb 19, 2026.

Industries' Descriptions

@Biotechnology (+1.24% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VIR($843M) has a higher market cap than CNSP($4.37M). CNSP YTD gains are higher at: 34.095 vs. VIR (0.498). CNSP has higher annual earnings (EBITDA): -13.05M vs. VIR (-541.01M). VIR has more cash in the bank: 507M vs. CNSP (9.86M). CNSP has less debt than VIR: CNSP (30.8K) vs VIR (100M). VIR has higher revenues than CNSP: VIR (14M) vs CNSP (0).
CNSPVIRCNSP / VIR
Capitalization4.37M843M1%
EBITDA-13.05M-541.01M2%
Gain YTD34.0950.4986,853%
P/E Ratio0.01N/A-
Revenue014M-
Total Cash9.86M507M2%
Total Debt30.8K100M0%
FUNDAMENTALS RATINGS
CNSP vs VIR: Fundamental Ratings
CNSP
VIR
OUTLOOK RATING
1..100
1155
VALUATION
overvalued / fair valued / undervalued
1..100
9
Undervalued
51
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10097
PRICE GROWTH RATING
1..100
3460
P/E GROWTH RATING
1..100
328
SEASONALITY SCORE
1..100
n/a75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CNSP's Valuation (9) in the null industry is somewhat better than the same rating for VIR (51). This means that CNSP’s stock grew somewhat faster than VIR’s over the last 12 months.

CNSP's Profit vs Risk Rating (100) in the null industry is in the same range as VIR (100). This means that CNSP’s stock grew similarly to VIR’s over the last 12 months.

VIR's SMR Rating (97) in the null industry is in the same range as CNSP (100). This means that VIR’s stock grew similarly to CNSP’s over the last 12 months.

CNSP's Price Growth Rating (34) in the null industry is in the same range as VIR (60). This means that CNSP’s stock grew similarly to VIR’s over the last 12 months.

CNSP's P/E Growth Rating (3) in the null industry is in the same range as VIR (28). This means that CNSP’s stock grew similarly to VIR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CNSPVIR
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
82%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
78%
MACD
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
76%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
76%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 4 days ago
74%
Declines
ODDS (%)
Bearish Trend 20 days ago
90%
Bearish Trend 2 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
CNSP
Daily Signal:
Gain/Loss:
VIR
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GMAWX25.650.03
+0.12%
GMO Small Cap Quality III
TIGRX15.24N/A
N/A
Nuveen Core Equity R6
SVXLX75.81N/A
N/A
Smead International Value Inv
MSPIX75.42-0.05
-0.07%
NYLI S&P 500 Index Class I
AIEMX14.02-0.02
-0.14%
Alger Emerging Markets I

CNSP and

Correlation & Price change

A.I.dvisor indicates that over the last year, CNSP has been loosely correlated with PMN. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if CNSP jumps, then PMN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNSP
1D Price
Change %
CNSP100%
-4.48%
PMN - CNSP
49%
Loosely correlated
+0.33%
VIR - CNSP
36%
Loosely correlated
-2.26%
AAVXF - CNSP
34%
Loosely correlated
N/A
MURA - CNSP
31%
Poorly correlated
N/A
PTGX - CNSP
30%
Poorly correlated
-3.26%
More

VIR and

Correlation & Price change

A.I.dvisor indicates that over the last year, VIR has been loosely correlated with BEAM. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if VIR jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VIR
1D Price
Change %
VIR100%
-2.26%
BEAM - VIR
59%
Loosely correlated
-2.59%
CLDX - VIR
56%
Loosely correlated
-0.16%
IDYA - VIR
54%
Loosely correlated
-0.61%
XNCR - VIR
54%
Loosely correlated
-3.18%
DNLI - VIR
54%
Loosely correlated
-4.21%
More